Date | Open(₹) | High(₹) | Low(₹) | Close(₹) | No. Of Trades(₹) | Total Turnover(₹) | Deliverable Quantity(₹) |
|---|---|---|---|---|---|---|---|
02-Jan-2026 | 1,110 | 1,115.9 | 1,103.2 | 1,106.5 | 51,816 | 1,05,83,60,052.5 | 5,00,297 |
05-Jan-2026 | 1,106.5 | 1,113.5 | 1,096.7 | 1,103.2 | 42,740 | 1,12,43,08,699.6 | 6,32,386 |
06-Jan-2026 | 1,134 | 1,134 | 1,105.2 | 1,115.9 | 36,975 | 1,26,87,88,145.8 | 4,81,801 |
07-Jan-2026 | 1,115.9 | 1,141 | 1,113.8 | 1,128.5 | 32,402 | 1,53,52,37,935.7 | 6,22,855 |
08-Jan-2026 | 1,131.9 | 1,131.9 | 1,092.7 | 1,100.9 | 43,283 | 1,53,39,76,226 | 7,08,979 |
09-Jan-2026 | 1,095 | 1,107.8 | 1,079.6 | 1,083 | 45,435 | 1,76,11,27,963.2 | 7,84,246 |
12-Jan-2026 | 1,085 | 1,087 | 1,025.3 | 1,043.2 | 81,825 | 2,53,73,33,848.5 | 9,12,265 |
13-Jan-2026 | 1,043.2 | 1,063.2 | 1,023.8 | 1,058.3 | 47,642 | 1,64,07,76,272.6 | 7,24,850 |
14-Jan-2026 | 1,063 | 1,098.9 | 1,057.8 | 1,090.5 | 58,047 | 2,59,26,14,818.4 | 11,98,301 |
16-Jan-2026 | 1,095 | 1,096.9 | 1,070.4 | 1,076.8 | 44,879 | 1,52,57,15,843.5 | 7,26,090 |
19-Jan-2026 | 1,067 | 1,075.8 | 1,052.2 | 1,062.7 | 46,886 | 4,41,39,12,112.1 | 30,95,644 |
20-Jan-2026 | 1,065 | 1,066.4 | 1,015 | 1,035.5 | 62,957 | 3,01,87,96,597 | 13,62,537 |
21-Jan-2026 | 1,033.6 | 1,050 | 980.1 | 987.9 | 56,249 | 2,50,55,05,816.7 | 10,56,528 |
22-Jan-2026 | 1,003 | 1,021.4 | 986.1 | 1,005.8 | 67,949 | 4,26,28,33,709.9 | 28,39,372 |
23-Jan-2026 | 1,017.9 | 1,044.8 | 1,000 | 1,016.4 | 85,970 | 4,29,63,13,445.2 | 11,85,096 |
27-Jan-2026 | 1,030 | 1,041 | 990.1 | 1,000.2 | 1,16,931 | 5,43,70,73,495.9 | 25,72,720 |
28-Jan-2026 | 1,010 | 1,012.6 | 987 | 999 | 45,423 | 1,97,46,84,616.4 | 10,68,309 |
29-Jan-2026 | 1,001.7 | 1,006.9 | 965.8 | 973.3 | 49,165 | 2,12,86,55,140.2 | 12,05,591 |
30-Jan-2026 | 974 | 983.3 | 951.8 | 965 | 47,591 | 1,91,23,25,596.3 | 10,37,905 |
Finished Dosage Formulations (FDF) business also saw a 27% growth, while the Generics business saw moderate growth of 5%
The said transaction falls under related party transactions. However, the same is being carried at arm’s length price.
IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000
IIFL Capital Services Support WhatsApp Number
+91 9892691696
Download The App Now
Follow us on
2026, IIFL Capital Services Ltd. All Rights Reserved
IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248, DP SEBI Reg. No. IN-DP-185-2016, BSE Enlistment Number (RA): 5016
ARN NO : 47791 (AMFI Registered Mutual Fund & Specialized Investment Fund Distributor), PFRDA Reg. No. PoP 20092018
This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.
